Stents Market Insights, Trends and Forecasts to 2022
- Submitted by: Marketreport
- Views: 89
- Category: Other
- Date Submitted: 06/07/2016 02:45 AM
- Pages: 4
- Report this Essay
Summary
According to Stratistics MRC, the Global Stents Market is valued at $8.43 billion in 2015 and is projected to grow to $12.13 billion by 2022 growing at a Compound Annual Growth Rate of 5.3%. Rising adoption of drug-eluting stents as a more efficient treatment for coronary heart disease, coupled with growing awareness among patients about stents, is anticipated to fuel the market growth. On the other hand strict regulations for approval of stents, abridged reimbursement and substitute methods and are hampering the market. The innovation of technological advanced products with lower re-stenosis occurrence rates such as bio-absorbable stents and the existence of high unmet medical needs in emerging Asian countries are some of the future growth opportunities of this market.
Browse Detail Report With TOC @
https://marketreportscenter.com/reports/283304/stents-global-market-outlook-2015-2022
Bare metal stents segment anticipated to have a turn down in revenue during the forecast period. Bio-absorbable stents segment is estimated to witness the highest CAGR during the forecast period. By Application, urological stents segment dominates the market and accounts for more than 50% market share. The global stent market is mostly controlled by three players Abbott Laboratories, Medtronic and Boston Scientific. However, small and medium companies from Asia and Europe have a significant share in terms of volume in developing economies.
Some of the key players in the market are Medtronic, Abbott Laboratories, Arterius, B. Braun, Biosensors International, Biotronik, Boston Scientific Corp., C.R. Bard Inc., Celonova Biosciences, Cook Medical, Cordis Corp., Covidien, Elixir Medical Corp., Inspiremd and Kyoto Me.
Device Covered:
Drug-Eluting Stents
Bioresorbable Stents
Bare-Metal Stents
Others
o Plastic Stents
o Self Expanding metal Stents
Application Covered:
Vascular stents
o Coronary Stents
o Peripheral stents
o Peripheral...
According to Stratistics MRC, the Global Stents Market is valued at $8.43 billion in 2015 and is projected to grow to $12.13 billion by 2022 growing at a Compound Annual Growth Rate of 5.3%. Rising adoption of drug-eluting stents as a more efficient treatment for coronary heart disease, coupled with growing awareness among patients about stents, is anticipated to fuel the market growth. On the other hand strict regulations for approval of stents, abridged reimbursement and substitute methods and are hampering the market. The innovation of technological advanced products with lower re-stenosis occurrence rates such as bio-absorbable stents and the existence of high unmet medical needs in emerging Asian countries are some of the future growth opportunities of this market.
Browse Detail Report With TOC @
https://marketreportscenter.com/reports/283304/stents-global-market-outlook-2015-2022
Bare metal stents segment anticipated to have a turn down in revenue during the forecast period. Bio-absorbable stents segment is estimated to witness the highest CAGR during the forecast period. By Application, urological stents segment dominates the market and accounts for more than 50% market share. The global stent market is mostly controlled by three players Abbott Laboratories, Medtronic and Boston Scientific. However, small and medium companies from Asia and Europe have a significant share in terms of volume in developing economies.
Some of the key players in the market are Medtronic, Abbott Laboratories, Arterius, B. Braun, Biosensors International, Biotronik, Boston Scientific Corp., C.R. Bard Inc., Celonova Biosciences, Cook Medical, Cordis Corp., Covidien, Elixir Medical Corp., Inspiremd and Kyoto Me.
Device Covered:
Drug-Eluting Stents
Bioresorbable Stents
Bare-Metal Stents
Others
o Plastic Stents
o Self Expanding metal Stents
Application Covered:
Vascular stents
o Coronary Stents
o Peripheral stents
o Peripheral...